Atlas Trials

Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection

Clinical trial NCT04553068 · COMPLETED

Trial details

NCT number
NCT04553068
Sponsor
Evofem Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Sexually Transmitted DiseasesGonorrheaChlamydia
Start date
2020-10-15
Primary completion
2022-07-28
Enrollment
1892

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.